{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:57:47Z","timestamp":1753891067835,"version":"3.41.2"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>CD20+ T-cells were described firstly in peripheral blood and later in bone marrow in patients with hematological tumors, and certain immune-mediated diseases. During our hematological diagnostic work, this peculiar subgroup of lymphocytes has been consistently observed associated with untreated monoclonal gammopathy of undetermined significance (MGUS) and myeloma (MM). Despite the expanding literature data, the exact function of CD20+ T cells remains unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated the incidence of CD20+ T-cells in MGUS (n=27), and MM using a larger cohort (n=125) and compared it with control bone marrow samples (n=39). We examined their presence before and after treatment in 32 cases with flow cytometry. Comprehensive flow cytometric analysis included the examination of functional (T-cell activation, cytotoxic molecules and T-cell exhaustion) and maturation markers in a large number of cases. In addition RNA sequencing and subsequent bioinformatics analyses were carried out to detect differentially expressed (DE) genes of FACS sorted CD20+ T-cells versus CD20- T-cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and discussion<\/jats:title><jats:p>We found that CD20+ T-cells are phenotypically and transcriptionally different from CD20- T-cells. Elevated incidence of CD20+ T-cells in MGUS and MM and the expression of CD8, NKG2D, and CD28 suggests anti-tumor functionality. Increased PD-1 expression indicates T-cell exhaustion which was mostly detected in the samples of patients with a higher tumor percentage. The majority of CD20+ T-cells are effector or effector memory T-cells. Some of the differentially expressed genes suggest antitumor function via regulating T-cell activation pathways, while other genes involved in tumor escape from immune surveillance by suppressing T-cells or by reprogramming T-cells toward T-cell exhaustion. Our findings suggest that CD20+ T-cells may play a vital role both in immune surveillance and immune escape contributing to progression of multiple myeloma.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1464940","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T07:16:53Z","timestamp":1740554213000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiparameter flow cytometric and transcriptional analyis of CD20 positive T-cells in bone marrow in patients of multiple myeloma and monoclonal gammopathy of undetermined significance"],"prefix":"10.3389","volume":"16","author":[{"given":"Barbara","family":"Forr\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Kajt\u00e1r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1gnes","family":"Lacza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Kereskai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Vida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bal\u00e1zs","family":"K\u0151szegi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e9ter","family":"Urb\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f3zsef","family":"Kun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Gyenesei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szabolcs","family":"Kosztol\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e1niel","family":"Kehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e1l","family":"J\u00e1ks\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cyto.990140212","article-title":"CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes","volume":"14","author":"Hultin","year":"1993","journal-title":"Cytometry: J Int Soc Analytical Cytol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/ajcp\/106.1.78","article-title":"CD20 (pan-B cell antigen) expression on bone marrow-derived T cells","volume":"106","author":"Algino","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.48.2141","article-title":"CD20-positive T-cell large granular lymphocyte leukemia: case report and review of the literature","volume":"48","author":"Miyazaki","year":"2009","journal-title":"Internal Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3880229","article-title":"CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin\u2019s disease and review of the literature","author":"Mohrmann","year":"2000","journal-title":"Mod Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/art.27527","article-title":"CD3+CD20+ cells may be an artifact of flow cytometry: comment on the article by Wilk et\u00a0al","volume":"62","author":"Henry","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600089","article-title":"Features of human CD3+CD20+ T cells","volume":"197","author":"Schuh","year":"2016","journal-title":"J Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2014.999536","article-title":"CD20+ T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer","volume":"4","author":"Marco de","year":"2015","journal-title":"OncoImmunology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e110138","DOI":"10.1371\/journal.pone.0110138","article-title":"CD3-positive B cells: a storage-dependent phenomenon","volume":"9","author":"Nagel","year":"2014","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1124\/mol.114.092684","article-title":"Analyses of CD20 monoclonal antibody mediated tumor cell killing mechanisms: rational design of dosing strategies","volume":"86","author":"Taylor","year":"2014","journal-title":"Mol Pharmacol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/nri1199","article-title":"Roles of the NKG2D immunoreceptor and its ligands","author":"Raulet","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3324\/haematol.2012.067272","article-title":"Spanish Myeloma Group (GEM); Grupo Castellano-Leones de Gammapatias Monoclonales, cooperative study groups. Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry","volume":"98","author":"Pessoa de Magalh\u00e3es","year":"2013","journal-title":"Haematologica"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04087","article-title":"Expansion of CD8+ T cells that express low levels of the B cell-specific molecule CD20 in patients with multiple myeloma","volume":"120","author":"Katopodis","year":"2003","journal-title":"Br J Haematol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.7.4330","article-title":"Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules","volume":"177","author":"Takata","year":"2006","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"5","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx096","article-title":"ESMO Guidelines Committee. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Moreau","year":"2017","journal-title":"Ann Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e0185056","DOI":"10.1371\/journal.pone.0185056","article-title":"BBMerge \u2013 Accurate paired shotgun read merging via overlap","volume":"12","author":"Bushnell","year":"2017","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"TR. STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2013a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1346211","article-title":"Different evasion strategies in multiple myeloma","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5114\/ceji.2022.117376","article-title":"Cancer immunoediting hypothesis: history, clinical implications and controversies","volume":"47","author":"Lasek","year":"2022","journal-title":"Cent Eur J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.3390\/cancers13133213","article-title":"Mechanisms of immune evasion in multiple myeloma: open questions and therapeutic opportunities","volume":"13","author":"Botta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.04.020","article-title":"CD28 costimulation: from mechanism to therapy","volume":"44","author":"Esensten","year":"2016","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0263","article-title":"Boosting cancer immunotherapy with anti-CD137 antibody therapy","volume":"21","author":"Yonezawa","year":"2015","journal-title":"Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.05.001","article-title":"Regulatory T cells","volume":"4","author":"Thompson","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00883","article-title":"Emerging functions of regulatory T cells in tissue homeostasis","volume":"9","author":"Sharma","year":"2018","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/178698","article-title":"NKG2D and DNAM-1 ligands: molecular targets for NK cell-mediated immunotherapeutic intervention in multiple myeloma","volume":"2015","author":"Fionda","year":"2015","journal-title":"BioMed Res Int"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.161","article-title":"Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy","volume":"15","author":"Prajapati","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0797-0","article-title":"Regulation of immune cell function and differentiation by the NKG2D receptor","volume":"68","author":"Zafirova","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31184","article-title":"LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems","volume":"117","author":"Grosso","year":"2007","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1003345107","article-title":"Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer","volume":"107","author":"Matsuzaki","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"Gros","year":"2014","journal-title":"J Clin Invest"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.7.4510-4513","article-title":"Complex memory T-cell phenotypes revealed by coexpression of CD62L and CCR7","volume":"79","author":"Unsoeld","year":"2005","journal-title":"J Virol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066","article-title":"LEF1 drives a central memory program and supports antitumor activity of natural killer T cells","volume":"11","author":"Ngai","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11438","article-title":"FAM65B controls the proliferation of transformed and primary T cells","volume":"7","author":"Froehlich","year":"2016","journal-title":"Oncotarget"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1129191","article-title":"NF\u03baB signaling in T cell memory","volume":"14","author":"Daniels","year":"2023","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0817","article-title":"The tumor suppressor TSLC1\/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM","volume":"106","author":"Boles","year":"2005","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00411","article-title":"Co-stimulatory blockade of the CD28\/CD80-86\/CTLA-4 balance in transplantation: impact on memory T cells","volume":"6","author":"Ville","year":"2015","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040863","article-title":"The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo","author":"Liu","year":"2005","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.06.060","article-title":"The ubiquitin ligase adaptor NDFIP1 selectively enforces a CD8+ T cell tolerance checkpoint to high-dose antigen","volume":"24","author":"Wagle","year":"2018","journal-title":"Cell Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112940","article-title":"SOCS3 deletion in effector T cells confers an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine","volume":"42","author":"Mise-Omata","year":"2023","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e404615e","DOI":"10.1097\/01.HS9.0000970192","article-title":"P822: epigenetic regulation of cd155 on multiple myeloma cells influences anti-tumor novel immunotherapeutic approaches","volume":"7","author":"Martinez-Verbo","year":"2023","journal-title":"Hemasphere"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI123955","article-title":"Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells","volume":"129","author":"Kamiya","year":"2019","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/bfgp\/ely006","article-title":"CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy","volume":"18","author":"He","year":"2019","journal-title":"Brief Funct Genomics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12672-024-00951","article-title":"Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8\u2009+\u2009T cell exhaustion","volume":"15","author":"Liang","year":"2024","journal-title":"Discovery Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1838141","article-title":"Tumor-infiltrating TNFRSF9+ CD8+ T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response","volume":"9","author":"Li","year":"2020","journal-title":"Oncoimmunology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1464940\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T07:16:56Z","timestamp":1740554216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1464940\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2025.1464940"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1464940","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"article-number":"1464940"}}